PRCT of FICB vs LAI for Hip Arthroscopy

Fascia Iliaca Compartment Block and Local Anaesthetic Infiltration for Pain Control Following Hip Arthroscopic Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02702661

Enrollment

Registered

2016-03-09

Start date

2013-03-31

Completion date

2014-04-30

Last updated

2016-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroacetabular Impingement

Keywords

Fascia Iliaca Block, Local Anaesthetic Infiltration, Hip Arthroscopy

Brief summary

A prospective randomised controlled trial involving patients undergoing hip arthroscopy. Participants were randomised to receiving either Fascia Iliaca Compartment Block (FICB) or Local Anaesthetic Infiltration (LAI) of the portal tracts with local anaesthetic. Supplemental analgesia was also used in both groups on an on-demand basis. Pain level is assessed at 1,3,6, and 24 hours post surgery. The primary outcome measure was the post-operative level of pain as assessed by Numeric Pain Score 6 hours after surgery. Secondary outcome measures were the frequency and the dose of morphine and other medications consumed at 1 and 24 hours after surgery as well as any other adverse events relating to pain or medications used for pain relief in both the groups.

Interventions

PROCEDUREFascia Iliaca Compartment Block (FICB)

Fascia Iliaca Compartment Block

PROCEDURELocal Anaesthetic Infiltration (LAI)

Local Anaesthetic Infiltration (LAI) of the portal tracts

DRUGLevobupivacaine

Levobupivacaine 0.125% - 40ml

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients over the age of 18 years * Primary elective hip arthroscopy on a native hip for combined soft tissue injuries and FAI pathology * Able to read, write and communicate in English

Exclusion criteria

* Patients who did not want to be involved in the Trial * Unable to give informed consent * Previous hip surgery * Patients younger than 18 years of age * Chronic opioids users * Patients known to have an allergy or intolerance to local anaesthetic agents or none steroidal anti-inflammatory medications

Design outcomes

Primary

Measure	Time frame
Level of pain as assessed by Numeric Pain Score	6 hours after surgery

Secondary

Measure	Time frame
Frequency of morphine consumed	1 and 24 hours after surgery
Total dose of morphine consumed	1 and 24 hours after surgery
Total dose of codeine consumed	1 and 24 hours after surgery
Nausea and Vomiting	1 and 24 hours after surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026